These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20884126)

  • 1. Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity.
    Rastmanesh R
    Med Hypotheses; 2011 Jan; 76(1):79-85. PubMed ID: 20884126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of melatonin in age-related macular degeneration.
    Yi C; Pan X; Yan H; Guo M; Pierpaoli W
    Ann N Y Acad Sci; 2005 Dec; 1057():384-92. PubMed ID: 16399908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible therapy for age-related macular degeneration using human telomerase.
    Rowe-Rendleman C; Glickman RD
    Brain Res Bull; 2004 Feb; 62(6):549-53. PubMed ID: 15036570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory role of HIF-1alpha in the pathogenesis of age-related macular degeneration (AMD).
    Arjamaa O; Nikinmaa M; Salminen A; Kaarniranta K
    Ageing Res Rev; 2009 Oct; 8(4):349-58. PubMed ID: 19589398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress.
    Liang FQ; Green L; Wang C; Alssadi R; Godley BF
    Exp Eye Res; 2004 Jun; 78(6):1069-75. PubMed ID: 15109913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGF.
    Kernt M; Neubauer AS; Liegl RG; Hirneiss C; Alge CS; Wolf A; Ulbig MW; Kampik A
    Br J Ophthalmol; 2010 Nov; 94(11):1533-9. PubMed ID: 20962354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases.
    Nagineni CN; Samuel W; Nagineni S; Pardhasaradhi K; Wiggert B; Detrick B; Hooks JJ
    J Cell Physiol; 2003 Dec; 197(3):453-62. PubMed ID: 14566975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of Telomerase in Age-Related Macular Degeneration-Involvement of Senescence, DNA Damage Response and Autophagy and a Key Role of PGC-1α.
    Blasiak J; Szczepanska J; Fila M; Pawlowska E; Kaarniranta K
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic physiology in age related macular degeneration.
    Stefánsson E; Geirsdóttir A; Sigurdsson H
    Prog Retin Eye Res; 2011 Jan; 30(1):72-80. PubMed ID: 20951826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological factors in the pathogenesis and treatment of age-related macular degeneration.
    Kijlstra A; La Heij E; Hendrikse F
    Ocul Immunol Inflamm; 2005 Feb; 13(1):3-11. PubMed ID: 15804763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction in age-related macular degeneration: melatonin as a potential treatment.
    Mehrzadi S; Hemati K; Reiter RJ; Hosseinzadeh A
    Expert Opin Ther Targets; 2020 Apr; 24(4):359-378. PubMed ID: 32116056
    [No Abstract]   [Full Text] [Related]  

  • 12. Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt.
    Byeon SH; Lee SC; Choi SH; Lee HK; Lee JH; Chu YK; Kwon OW
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1190-7. PubMed ID: 19834034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin in Retinal Physiology and Pathology: The Case of Age-Related Macular Degeneration.
    Blasiak J; Reiter RJ; Kaarniranta K
    Oxid Med Cell Longev; 2016; 2016():6819736. PubMed ID: 27688828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial ferritin affects mitochondria by stabilizing HIF-1α in retinal pigment epithelium: implications for the pathophysiology of age-related macular degeneration.
    Wang X; Yang H; Yanagisawa D; Bellier JP; Morino K; Zhao S; Liu P; Vigers P; Tooyama I
    Neurobiol Aging; 2016 Nov; 47():168-179. PubMed ID: 27599360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced zinc and copper in the retinal pigment epithelium and choroid in age-related macular degeneration.
    Erie JC; Good JA; Butz JA; Pulido JS
    Am J Ophthalmol; 2009 Feb; 147(2):276-282.e1. PubMed ID: 18848316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of the RPE in AMD.
    Binder S; Stanzel BV; Krebs I; Glittenberg C
    Prog Retin Eye Res; 2007 Sep; 26(5):516-54. PubMed ID: 17532250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunction of the retinal pigment epithelium with age: increased iron decreases phagocytosis and lysosomal activity.
    Chen H; Lukas TJ; Du N; Suyeoka G; Neufeld AH
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1895-902. PubMed ID: 19151392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.
    Cashman SM; Bowman L; Christofferson J; Kumar-Singh R
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3496-504. PubMed ID: 16877421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth-related effects of oxidant-induced stress on cultured RPE and choroidal endothelial cells.
    Eichler W; Reiche A; Yafai Y; Lange J; Wiedemann P
    Exp Eye Res; 2008 Oct; 87(4):342-8. PubMed ID: 18640112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.